HEIDI: Rogmans, Christoph: ADAM17 - UB Heidelbergkatalog.ub.uni-heidelberg.de › titel
katalog.ub.uni-heidelberg.de
... Norbert Arnold, Jörg Paul Weimer, Inken Flörkemeier, Anna-Christina Rambow, Wolfgang Lieb, Nicolai Maass, Dirk O. Bauerschlag and Nina Hedemann.
Nina Hedemann | XanEdu Customization Platform
www.academicpub.com
Author: Nina Hedemann. Results. ADAM17-overexpressing breast cancer cells selectively targeted by antibody–toxin conjugates Springer ...
Die Metalloprotease ADAM17: potentieller Tumormarker und ...books.google.com › books › about › Die_Metalloprotease_ADAM17
books.google.com
Nina Hedemann Reviews. Reviews aren't verified, but Google checks for and removes fake content when it's identified ...
Die Metalloprotease ADAM17: potentieller Tumormarker und...
books.google.de
Front Cover. Nina Hedemann pages. 0 Reviewshttps://books.google.com/books/about/Die_Metalloprotease_ADAM17.html?id=rU_VoAEACAAJ ...
[PDF] Inhibition of ADAM17 impairs endothelial cell UCL Discoverydiscovery.ucl.ac.uk › jem_
discovery.ucl.ac.uk
Nina Hedemann (University Hospital Kiel, Kiel,. Germany). HUVECs were from PromoCell. HMVEC-L were from. Lonza. LLC-LacZ, B16F1-LacZ, ADAM17-deficient HEK293T ...
ADAM17 promotes lymph node metastasis in gastric cancer ...
www.spandidos-publications.com
— Nina Hedemann et al, 2021, Cancers CrossRef; Immunosuppressant Therapies in COVID-19: Is the TNF Axis an ... Twitter · LinkedIn · Facebook. › ...
Die Metalloprotease ADAM17 - potentieller Tumormarker und...
macau.uni-kiel.de
Nina Hedemann : URN:NBN: urn:nbn:de:gbv:8-diss : Fakultät: Medizinische Fakultät: DDC Sachgebiet: 610 Medizin und Gesundheit : Datum der mdl. Prüfung: …
Nils Tribian | PubFactswww.pubfacts.com › author › Nils+Tribian
www.pubfacts.com
· ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids. Authors: Nina Hedemann Andreas Herz Jan Hendrik ...
ADAM17-overexpressing breast cancer cells selectively targeted by...
link.springer.com
Nina Hedemann · Kosuke Yamamoto · André Mauermann · Christine Desel · Inken Lorenzen ·. Hilmar Lemke · Stefan Rose-John · Joachim ...
Alle Infos zum Namen "Nina Hedemann"
ADAM17-overexpressing breast cancer cells selectively targeted by...
www.bionity.com
Ahmad Trad, Hinrich P. Hansen, Mohammad Shomali, Matthias Peipp, Katja Klausz, Nina Hedemann, Kosuke Yamamoto, André Mauermann, Christine Desel, Inken Lorenzen, Hilmar
ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in ...researchain.net › papers
researchain.net
Nina Hedemann. Andreas Herz. Jan Hendrik Schiepanski. Jan Dittrich. Susanne Sebens. Astrid Dempfle. Julia Feuerborn. Christoph Rogmans. Nils Tribian.
ADAM17 promotes lymph node metastasis in gastric cancer via ...
www.spandidos-publications.org
Nina Hedemann et al, 2021, Cancers CrossRef; Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative? ... Twitter · LinkedIn · Facebook. › ...
Cancers | Free Full-Text | ADAM17 Inhibition Increases MDPI
www.mdpi.com
von N Hedemann · · Zitiert von: 7 — ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids. by. Nina Hedemann. 1,*,. Andreas Herz. › ...
ADAM17 inhibition enhances platinum efficiency in ovarian cancerwww.oncotarget.com › article
www.oncotarget.com
· https://doi.org oncotarget Nina Hedemann, Christoph Rogmans, Susanne Sebens, Daniela Wesch, Manuel Reichert, ...
ADAM17-一种潜在的基于血液的生物标志物 - X-MOLwww.x-mol.com › paper
www.x-mol.com
· ... Inken Flörkemeier 1 , Anna-Christina Rambow 1 , Wolfgang Lieb 5 , Nicolai Maass 1 , Dirk O Bauerschlag 1 , Nina Hedemann 1. Affiliation.
Inhibition of ADAM17 impairs endothelial cell necroptosis and ...
rupress.org
von J Bolik · · Zitiert von: 8 — LLC and B16F1 cells were from Cell Lines Service. MDA-MB231 were provided by Dr. Nina Hedemann (University Hospital Kiel, Kiel, Germany). HUVECs ... › jem › article
sortiert nach Relevanz / Datum